Abstract:PL03-01 Recent research in a variety of tumor systems has given support to the Cancer Stem Cell Hypothesis. Two important components of this hypothesis are that tumors originate in tissue stem or progenitor cells as a result of disregulation of the normally tightly regulated process of self-renewal. As a result of this, tumors contain and are driven by a cellular subcomponent that retains key stem cell properties including self-renewal which drives tumorigenesis and differentiation that contributes to cellular heterogeneity. The Cancer Stem Cell Hypothesis has profound implications for the early detection, prevention, and treatment of cancer. Our laboratory has developed techniques for the isolation and characterization of stem cells from human mammary glands and mammary carcinomas. Mammary stem and progenitor cells can be cultured in vitro as floating spherical colonies which we have termed which are composed of progenitor cells capable of multi-lineage differentiation, as well as stem cells capable of mammosphere formation. These more primitive cells express the stem cell markers OCT-4, Bmi-1, and ALDH-1. Mammosphere initiating cells which are estrogen receptor negative give rise to estrogen receptor positive proliferating progenitor We have utilized these in vitro systems as well as a humanized NOD-SCID mouse model to study the developmental pathways which regulate stem cell self-renewal and lineage specific commitment. Both Notch and Hedgehog signaling are involved in stem cell self-renewal as evidenced by the observation that activation of these pathways increases mammosphere number upon serial passage. These effects are mediated by the polycomb gene Bmi-1. Over expression of the Hedgehog component Gli-2 in mammosphere initiating cells results in the generation of ductal hyperplasias when these cells are implanted into the mammary fat pads of humanized NOD-SCID mice. In contrast, inhibition of Bmi-1 utilizing a siRNA lenti virus inhibits mammosphere formation in vitro and mammary gland development in these mice. These results suggest that disregulation of normal stem cell self-renewal results in expansion of stem cell pools which may then serve as targets for further transformational events. We have previously reported the isolation of a subpopulation of cells within human breast cancers which display stem cell characteristics. These cells characterized as CD44+ CD24 low lin- display activated Hedgehog signaling and increased expression of Bmi-1. In order to define markers which might prove useful for in situ characterization of normal and malignant mammary stem cells, we have examined the expression of aldehyde dehydrogenase (ALDH) an enzyme previously found to be expressed in hematopoietic and neuronal stem ALDH may be assessed by the Aldefluor assay which utilizes a fluorescent probe to detect cells displaying aldehyde dehydrogenase activity. We have found that the Aldefluor positive population of normal mammary epithelium has stem cell characteristics as demonstrated by mammosphere formation and generation of ductal alveolar structures in humanized NOD-SCID mice. Furthermore, in human mammary carcinoma xenografts, Aldeflour positive cells display properties of stem cells. As few as 200 Aldefluor positive cells, which comprise between 1-10% of the tumor cell population, produce tumors in NOD-SCID mice while 2x10 3 Aldefluor negative cells failed to generate tumors. Consistent with the Aldefluor positive population representing cancer stem cells, tumors generated from this population recapitulate the phenotypic heterogeneity of ALDH expression seen in the original tumor. Based on the above studies, we utilized immunochemistry to detect ALDH-1 as a marker of normal and malignant mammary stem/progenitor cells in situ. ALDH-1 antibodies detect a rare cell population in normal human mammary gland and in mammospheres generated from these Expanded ALDH-1 positive populations are found in pre-malignant lesions such as ductal carcinoma in situ (DCIS) and at areas of microinvasion. Furthermore, utilizing tumor tissue microarrays, we have determined that expression of ALDH-1 is associated with a poor clinical outcome. These studies demonstrate that ALDH-1 may be utilized to detect normal and malignant human mammary stem/progenitor cells providing a new tool for the early detection of beast cancer. Furthermore, since these cells may drive carcinogenesis, strategies aimed at their elimination, represents a rational approach for cancer prevention.

Engineering Amyloid Aggregation as a New Way to Eliminate Cancer Stem Cells by the Disruption of Iron Homeostasis

Abstract 1281: Endothelial Cells Promote the Cancer Stem Cell Phenotype of Human Colorectal Cancer Cells

Gd-metallofullerenol Nanomaterial As Non-Toxic Breast Cancer Stem Cell-Specific Inhibitor

Cancer Stem Cell Regulated Phenotypic Plasticity Protects Metastasized Cancer Cells from Ferroptosis

An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a “Three-Pronged” strategy in breast cancer stem cells

Implications of the Cancer Stem Cell Hypothesis for the Early Detection and Prevention of Breast Cancer.

Anti-metastatic breast cancer potential of novel nanocomplexes of diethyldithiocarbamate and green chemically synthesized iron oxide nanoparticles

Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling

Iridium Nanozyme-Mediated Photoacoustic Imaging-Guided NIR-II Photothermal Therapy and Tumor Microenvironment Regulation for Targeted Eradication of Cancer Stem Cells

Abstract 4266: Potential role of reactive oxygen species in affecting tumorigenicity of glioblastoma stem cells

Abstract A043: Senescent CAFs modulate tumor immunity and promote breast cancer progression

Embryonic stem and haematopoietic progenitor cells resist to Aβ oligomer toxicity and maintain the differentiation potency in culture

Intracellular Mutual Promotion of Redox Homeostasis Regulation and Iron Metabolism Disruption for Enduring Chemodynamic Therapy

Manipulating Redox Homeostasis of Cancer Stem Cells Overcome Chemotherapeutic Resistance Through Photoactivatable Biomimetic Nanodiscs.

Phenethyl Isothiocyanate Suppresses Stemness in the Chemo- and Radio-Resistant Triple-Negative Breast Cancer Cell Line MDA-MB-231/IR Via Downregulation of Metadherin

Nanoparticle-Mediated Inhibition of Mitochondrial Glutaminolysis to Amplify Oxidative Stress for Combination Cancer Therapy

The Eradication of Breast Cancer Cells and Stem Cells by 8-Hydroxyquinoline-loaded Hyaluronan Modified Mesoporous Silica Nanoparticle-Supported Lipid Bilayers Containing Docetaxel

Alleviating neuronal inflammation induced by Aβ42 in SH-SY5Y through interaction with polysialic acid-oligomannuronate conjugate

Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy

Abstract 3349: Transformation of Mammary Epithelial Cells by Inactivation of P53 and PTEN Generates Cancer Stem Cells Driven by an IL-6/TGF-beta Inflammatory Loop

Abstract 3969: Alzheimer's disease-associated amyloid precursor protein improves anti-tumor immunity by inhibiting ceramide-mediated lethal mitophagy and restoring mitochondrial fumarate metabolism in aging T-cells